Capricor Therapeutics (CAPR) Net Margin (2011 - 2024)
Capricor Therapeutics' Net Margin was -63.77% in Q4 2024, down 57.46 percentage points from -6.30% a year earlier but up 491.44 percentage points from the prior quarter.
Capricor Therapeutics (CAPR) Net Margin (2011 - 2024) Analysis & Trends
For FY2024, Net Margin at Capricor Therapeutics came in at -181.47%, down 92.95 percentage points from FY2023.
- Net Margin shows a five-year change of +578.89 percentage points (FY2019 to FY2024).
- In earlier years, Net Margin was -88.52% in FY2023 (+1048.85 pp), -1137.37% in FY2022 (+7038.50 pp), -8175.86% in FY2021 (-3773.92 pp) and -4401.94% in FY2020 (-3641.58 pp).
- Quarterly Net Margin has moved between -23187.59% (Q3 2020) and -6.30% (Q4 2023) over five years.
- Compared with a year earlier, Net Margin has declined for three straight quarters, with an average year-over-year change of +92.87 percentage points over the last six quarters.
- The best year-over-year quarter for Net Margin over five years was Q2 2021 (a gain of 4660.67 percentage points); the worst was Q3 2020 (a drop of 22056.75 percentage points).
- Per Business Quant data, CAPR's Net Margin in the three quarters before Q4 2024 was -555.20% (Q3 2024), -276.97% (Q2 2024) and -199.60% (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Capricor Therapeutics | 515.69 Mn | -516.56 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -63.77% |
| Sep 30, 2024 | -555.20% |
| Jun 30, 2024 | -276.97% |
| Mar 31, 2024 | -199.60% |
| Dec 31, 2023 | -6.30% |
| Sep 30, 2023 | -103.31% |
| Jun 30, 2023 | -188.04% |
| Mar 31, 2023 | -260.10% |
| Dec 31, 2022 | -804.34% |
| Sep 30, 2022 | -400.30% |
| Jun 30, 2021 | -2,326.65% |
| Mar 31, 2021 | -12,622.31% |
| Dec 31, 2020 | -7,224.51% |
| Sep 30, 2020 | -23,187.59% |
| Jun 30, 2020 | -6,987.31% |
| Mar 31, 2020 | -1,122.72% |
| Dec 31, 2019 | -661.60% |
| Sep 30, 2019 | -1,130.84% |
| Jun 30, 2019 | -498.71% |
| Mar 31, 2019 | -1,092.97% |
Capricor Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CAPR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CAPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CAPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();